Cabrera, S. M., Wang, X., Chen, Y.-G., Jia, S., Kaldunski, M. L., Greenbaum, C. J., Mandrup-Poulsen, T., Hessner, M. J., Type 1 Diabetes TrialNet Canakinumab Study Group
& Rungby, J. (2016).
Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset.
European Journal of Immunology,
46(4), 1030-46.
https://doi.org/10.1002/eji.201546005
Cao, H., Bertolino, A., Walter, H., Schneider, M., Schäfer, A., Taurisano, P., Blasi, G., Haddad, L., Grimm, O., Otto, K., Dixson, L., Erk, S., Mohnke, S., Heinz, A., Romanczuk-Seiferth, N., Mühleisen, T. W.
, Mattheisen, M., Witt, S. H., Cichon, S. ... Meyer-Lindenberg, A. (2016).
Altered Functional Subnetwork During Emotional Face Processing: A Potential Intermediate Phenotype for Schizophrenia.
JAMA Psychiatry,
73(6), 598-605.
https://doi.org/10.1001/jamapsychiatry.2016.0161
Christensen, M. H., Jensen, S. B., Miettinen, J. J.
, Luecke, S., Prabakaran, T., Reinert, L. S., Mettenleiter, T., Chen, Z. J., Knipe, D. M., Sandri-Goldin, R. M., Enquist, L. W.
, Hartmann, R., Mogensen, T. H., Rice, S. A., Nyman, T. A., Matikainen, S.
& Paludan, S. R. (2016).
HSV-1 ICP27 targets the TBK1-activated STING signalsome to inhibit virus-induced type I IFN expression.
The EMBO Journal,
35(13), 1385-1399.
https://doi.org/10.15252/embj.201593458
Clausen, B. H., Lambertsen, K. L.
, Dagnæs-Hansen, F., Babcock, A. A., von Linstow, C. U., Meldgaard, M., Kristensen, B. W., Deierborg, T.
& Finsen, B. (2016).
Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke.
Acta Neuropathologica,
131(5), 775-791.
https://doi.org/10.1007/s00401-016-1541-5